A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2001
11/27/2001	CA1341322C Interleukin-1 inhibitors
11/26/2001	CA2346163A1 Complex for transferring an anionic substance of interest into a cell
11/26/2001	CA2316405A1 Modulation of inflammation by protease products
11/26/2001	CA2307705A1 Modulation of inflammation by protease products
11/25/2001	CA2307128A1 Pt32 sperm protein, oocyte cytoplasmic c-yes, and uses thereof
11/24/2001	CA2309236A1 Cross-linked hemoglobins for transport and delivery of nitric oxide
11/24/2001	CA2309235A1 Fusion polypeptides
11/22/2001	WO2001088199A2 Identification and modulationof of a t helper-1 and t helper-2 cells
11/22/2001	WO2001088198A1 Antisense modulation of tert expression
11/22/2001	WO2001088180A2 Tnf and ifn stimulated genes and uses therefor
11/22/2001	WO2001088158A1 A novel polypeptide- human triose-phosphate isomerase 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001088153A1 Novel polypeptide...a nadh ubiquinone oxidoreductase 14 and polynucleotide encoding it
11/22/2001	WO2001088151A1 Novel polypeptide - a human microglobulin transcriptional control factor 30 and polynucleotide encoding it
11/22/2001	WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	WO2001088146A1 A novel polypeptide, a human alkylation-dna-protein cysteine methyltransferase 11 and the polynucleotide encoding the polypeptide
11/22/2001	WO2001088137A2 Human myd88 adapter-like protein and functional fragments thereof
11/22/2001	WO2001088135A2 G-protein coupled receptor proteins and nucleic acids encoding same
11/22/2001	WO2001088134A2 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001	WO2001088131A1 Regulation of mt1-mmp activity
11/22/2001	WO2001088130A1 Molecular cloning and identification of a human leukotriene-like receptor ltxr
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088124A2 Method and reagent for the inhibition of erg
11/22/2001	WO2001088123A1 Ligands specific for an isoform of the prion protein
11/22/2001	WO2001088122A2 Erg modulators
11/22/2001	WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088112A1 A novel polypeptide, a human focal adhesion kinase (fak) 13 and the polynucleotide encoding the polypeptide
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001	WO2001088105A2 Production of dendritic cells from bone-marrow stem cells
11/22/2001	WO2001088103A2 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	WO2001088098A2 Fertilization of aged oocytes
11/22/2001	WO2001088092A2 Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides
11/22/2001	WO2001088091A2 Novel bone marrow nucleic acids and polypeptides
11/22/2001	WO2001088088A2 Novel nucleic acids and polypeptides
11/22/2001	WO2001088085A2 Novel bee venom polypeptides and methods of use thereof
11/22/2001	WO2001088059A1 Drilling fluids and method of drilling
11/22/2001	WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087978A2 Human abc transporter and its use
11/22/2001	WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087973A1 A novel polypeptide-human aldo-keto reductase 9.9 and a polynucleotide encoding the same
11/22/2001	WO2001087971A1 A novel polypeptide, human ribosomal protein s18-14 and the polynucleotide encoding thereof
11/22/2001	WO2001087969A1 A novel polypeptide, human sox9 protein 13 and the polynucleotide encoding thereof
11/22/2001	WO2001087966A1 A new polypeptide-human pax protein 22 and the polynucleotide encoding it
11/22/2001	WO2001087963A1 A new polypeptide- human ribosomal protein s18-12 and the polynucleotide encoding it
11/22/2001	WO2001087962A1 A new polypeptide-human pax protein 11 and the polynucleotide encoding it
11/22/2001	WO2001087960A1 A new polypeptide-human kruppel-related dna-binding protein 10 and the polynucleotide encoding it
11/22/2001	WO2001087959A1 A new polypeptide-human pax protein 11.9 and the polynucleotide encoding it
11/22/2001	WO2001087958A2 CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS
11/22/2001	WO2001087956A1 A novel polypeptide - deae and deah box family atp-dependent helicase 50 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087955A1 A novel polypeptide-dna mismatch repair protein 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087954A1 A novel polypeptide, a human clathrin light chain 9 and the polynucleotide encoding the polypeptide
11/22/2001	WO2001087953A1 A novel polypeptide-homo galactokinase 11 and polynucleotide encoding said polypeptide
11/22/2001	WO2001087952A1 A novel polypeptide-homo ribosomal protein 13 and polynucleotide encoding said polypeptide
11/22/2001	WO2001087951A1 A novel polypeptide -homo helicase 11 and polynucleotide encoding said polypeptide
11/22/2001	WO2001087950A1 A novel polypeptide -human cannabinoid receptor 11 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087948A1 A novel polypeptide -human aldehyde/ketoreductase 12 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087947A1 A novel polypeptide-human ccr4 protein 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087945A1 The novel polypeptide-human laminin b2 chain 12 and the polynucliotide encoding said polypeptide
11/22/2001	WO2001087944A1 A novel polypeptide-human protein 10 characterized in that it comprises the sequence of gamma glutamyl transpeptidase and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087942A1 A novel polypeptide -human phosphatidase 13 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087941A1 A novel polypeptide-human kringle protein 14 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087939A2 Genes required for natural competence, proteins, and their use
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001	WO2001087930A2 Human galanin receptor-like g protein coupled receptor
11/22/2001	WO2001087929A2 Regulation of human dopamine-like g protein-coupled receptor
11/22/2001	WO2001087928A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087922A2 Derivatisation of proteins in aqueous solution
11/22/2001	WO2001087917A1 Novel nucleic acids and polypeptides
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087836A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
11/22/2001	WO2001087835A1 Α crystalline form of perindopril tert-butylamine salt
11/22/2001	WO2001087376A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
11/22/2001	WO2001087374A1 Delivery systems for treatment of vascular disease
11/22/2001	WO2001087373A1 Delivery devices for treatment of vascular disease
11/22/2001	WO2001087351A1 Method for treatment of tumors using nucleic acid ligands to pdgf
11/22/2001	WO2001087349A1 Carcinostatic agents or antiviral agents containing irg27 protein or gene
11/22/2001	WO2001087348A2 Multifunctional nanodevice platform
11/22/2001	WO2001087346A2 Dendritic cells loaded with toxic substances
11/22/2001	WO2001087342A2 Delivery devices for treatment of vascular disease
11/22/2001	WO2001087339A1 Antithrombotic agents
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087336A1 Cancer treatments by using a combination of an antibody against her2 and interleukin -2
11/22/2001	WO2001087335A2 Method for selectively inhibiting ghrelin action
11/22/2001	WO2001087333A2 Immune system stimulating means
11/22/2001	WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001	WO2001087329A1 Liquid pharmaceutical composition containing an erythropoietin derivate
11/22/2001	WO2001087328A2 Interleukin-1 inhibitors in the treatment of diseases
11/22/2001	WO2001087327A1 Method for cell adhesion and wound healing
11/22/2001	WO2001087326A1 Use of an enterobacterium ompa protein as antimicrobial agent

1 ... 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 ... 3163